Weis Holgerinsider trades

In SEC Form 4 filings, Weis Holger is listed as CEO of Alaunos Therapeutics, Inc. (TCRT). Weis Holger reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 8.

Companies and roles

Company	Role	Transactions	Last filed
TCRTAlaunos Therapeutics, Inc.	CEO	1	Oct 8

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-08

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
TCRTAlaunos Therapeutics, Inc.	Oct 6	Oct 8	A	23,564	$0.74	$17,541	49,047	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.